Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xg pseudogene, Y-linked 2 (abbreviated XGY2) is a pseudogene found on the Y chromosome in humans. As a pseudogene, it is a DNA sequence similar to the functional XG gene but carries mutations or disruptions that render it nonfunctional as a protein-coding gene. Pseudogenes such as XGY2 do not encode functional proteins and generally do not have direct biological roles; however, some pseudogenes may have regulatory roles such as acting as miRNA decoys, but no specific regulatory or disease-association data exist for this gene. XGY2 is not considered a therapeutic target, and there are no drugs or biomarkers associated with this locus. Supporting Details & Context: - Pseudogenes are classified as nonfunctional gene relics that may arise by gene duplication, retrotransposition, or disabling mutations, and are usually not translated into functional proteins. - Some pseudogenes can have roles in gene regulation or serve as disease mechanisms if involved in gene conversion, but no evidence indicates XGY2 does so. - XGY2 is not included in gene or protein interaction datasets, nor is it implicated in clinical or pharmacological pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xg pseudogene, Y-linked 2 (XGY2).